News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2016 Shelley Wood September 30, 2016
News Daily News Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT Michael O'Riordan September 29, 2016
News Daily News Chelation Encore: TACT2 Trial Gets Go-ahead for Controversial Post-MI Treatment in Diabetes Shelley Wood September 28, 2016
News Daily News Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV Michael O'Riordan September 20, 2016
News Opinion Editor's Corner ESC 2016 My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance Shelley Wood September 08, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Screening for and Treating Asymptomatic Extracoronary Disease No Help in High-risk CAD Todd Neale August 29, 2016
News Conference News ESC 2016 Long-term Exposure to Lower LDL Cholesterol, Blood Pressure Has Potential to Dramatically Cut CV Risk Todd Neale August 29, 2016
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016
News Daily News Beta-Blockers Not Beneficial After PCI for Stable Angina Michael O'Riordan August 17, 2016
News Daily News Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients Michael O'Riordan August 16, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Amount of Calcium, Not Calcium Progression, May Be Best for Gauging CV Risk Michael H. Wilson July 07, 2016
News Daily News Now You See It: FDA Approves Absorb Bioresorbable Scaffold Michael O'Riordan July 05, 2016
News Daily News Precious Time: Questionable Treatments Often Used at the End of Life Todd Neale June 30, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Conference News EuroPCR 2016 Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction Yael L. Maxwell May 17, 2016
News Daily News Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues Yael L. Maxwell May 04, 2016
News Daily News Very Elderly STEMI Patients Do Better With PCI, but ‘Eyeballing’ Is Insufficient for Decision Making L.A. McKeown May 02, 2016